How big is the circulating tumor cells market?

The global circulating tumor cells market size was estimated at USD 14.04 billion in 2025 and is expected to reach USD 15.64 billion in 2026.

What is the circulating tumor cells market growth?

The global circulating tumor cells market is expected to grow at a compound annual growth rate of 13.92% from 2026 to 2033 to reach USD 38.95 billion by 2033.

Which segment accounted for the largest circulating tumor cells market share?

In 2025, the CTC detection and enrichment methods segment accounted for the largest revenue share of 50.68%. The availability of different methods for the enrichment of circulating tumor cells in cancer detection is expected to significantly impact segment growth over the forecast period.

Who are the key players in the circulating tumor cells market?

Some key players operating in the CTCs market include QIAGEN; Bio-Techne Corporation; Precision Medicine Group, LLC.; Bio-Rad Laboratories, Inc.; Natera, Inc.; Illumina, Inc.; Cell Microsystems; Greiner Bio One International GmbH; Ikonisys Inc.; Miltenyi Biotec;

What are the factors driving the circulating tumor cells market?

Key factors that are driving the circulating tumor cells market growth include rising cancer prevalence, increasing preference for non-invasive cancer diagnosis, and technological advancements in CTC isolation and analysis.